You are here

Coronary Intervention & Surgery


Hospitals ranked in the top 50 for cardiology and heart surgery by U.S. News and World Report appear no better at performing PCI than unranked hospitals, according to an analysis of more than 500,000 procedures performed at 654 hospitals.

PCI of chronic total occlusions (CTOs) can be safely performed by expert operators and provides significant benefit to patients with reduced left ventricular ejection fraction (LVEF) or diabetes, according to a series of studies published Nov. 13 in JACC: Cardiovascular Interventions.

Scaffold discontinuity, malapposition and neoatherosclerosis were found to be the leading mechanisms behind very late scaffold thrombosis (VLScT) in cardiac patients implanted with bioresorbable devices, investigators from the INVEST registry have reported.

Recent studies have shown robotic PCI to be a feasible way to treat coronary artery disease. But at the annual Transcatheter Cardiovascular Therapeutics (TCT) conference Oct. 30, Ryan D. Madder, MD, took the conversation a step further: Will it eventually be possible to perform “tele-stenting” over long distances?

Research presented Nov. 2 at the Transcatheter Cardiovascular Therapeutics scientific symposium in Denver demonstrates patients with stable coronary artery disease (CAD) and abnormal fractional flow reserve (FFR) derive better clinical outcomes with PCI at similar cost to medical therapy alone.


Recent Headlines

TCT 2017: PCI, CABG yield similar long-term results for left main CAD patients

Heart patients with left main coronary artery disease (LMCAD) could benefit from more immediate results when receiving percutaneous coronary intervention (PCI) over coronary artery bypass graft surgery (CABG), according to research presented at this year’s Transcatheter Cardiovascular Therapeutics (TCT) symposium, though both procedures yield similar quality of life improvements after three years.

TCT 2017: PCI, TAVR anniversaries spur forward-looking discussions

DENVER — Before the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium kicked into full swing Oct. 30, a pair of doctors drew attention to two important anniversaries for interventional cardiology. The first PCI was performed 40 years ago and the first transcatheter aortic valve replacement (TAVR) was completed 15 years ago.

Cardiologist’s Twitter poll highlights TCT trials of greatest interest

Several of the late-breaking clinical trials presented at the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Denver next week are sure to generate significant interest in the cardiology community. Some could even change practice, according to experts in the field.

Chewing—not just swallowing—ticagrelor helps the blood thinner work faster

Chewing blood thinner ticagrelor rather than simply swallowing the pill could yield more effective results in patients suffering from ST-segment elevation myocardial infarction (STEMI), research published in JAMA Cardiology this week suggests.

Women, minorities see higher risk of ischemic events than white men following stent implantation

Women and minorities experience a higher risk of recurrent ischemic events than white men following everolimus-eluting stent implantation, a JAMA Cardiology study recently found.

5 topics to watch at TCT 2017

The 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium kicks off in Denver in less than two weeks. In preparation, Gregg W. Stone, MD, co-director of medical research and education at the Cardiovascular Research Foundation, provided some expected highlights of this year’s session Oct. 16 during a press briefing.

Internists, surgeons both overestimate risk; researcher calls for curriculum revamp

Residents in general surgery and internal medicine both vastly overestimated patients’ risk of postsurgical complications compared to a validated algorithm, a new study found.

Long-term study supports broader use of multiple arterial grafting

Multiple arterial grafting (MAG) was associated with lower rates of death and revascularization over 15 years of follow-up than the standard form of coronary artery bypass grafting (CABG), according to a study in JAMA Cardiology.

Inexpensive urine test helps surgeons ID kidney injury after open heart surgery

New research out of a Fort Meyers, Florida, health center has yielded a simple and effective urine test that can detect a patient’s risk for kidney injury after open heart surgery.

Transcatheter system shows positive 1-year results in treating tricuspid regurgitation

The first patients to receive Edwards Lifesciences’ FORMA system to treat severe tricuspid regurgitation (TR) demonstrated significant clinical improvements one year after implantation, according to a study in JACC: Cardiovascular Interventions.